Udayavni Special

Privatising two PSBs: Ind-Ra warns of rating impact if govt cedes control


PTI, Mar 24, 2021, 3:13 PM IST

Mumbai: Privatisation of two public sector banks can impact their ratings as the government support to the two entities will disappear, India Ratings and Research said on Wednesday.

The rating agency said the budget proposal to privatise the as yet unidentified PSBs “could lead to material negative migration of the long-term issuer ratings (mapped to senior instruments such as infrastructure bonds) and the ratings on Tier 2 instruments of the identified banks”.

The impact will be more if the government chooses to privatise the weaker banks, which are yet to be consolidated, it added.

Factoring in timely intervention from the government and minimal probability of default, the agency said it has a rating floor of ”IND AA-” for senior instruments and Tier 2 instruments of banks, which are majority-owned by the government.

The agency explained that it establishes a long-term issuer rating and equates the rating on senior issuances like infrastructure bonds and Tier-2 sub-debt to it.

The long-term issuer rating is arrived at a higher support-driven rating, factoring in the extraordinary distress support and the standalone credit profile of the issuer, which may factor in the ordinary ongoing support, it added.

In the case of hybrid instruments like additional tier-1 bonds, the rating is based on the standalone profile that factors in ordinary support from the government for PSBs as terms of these instruments could, under certain circumstances, prevent the support for servicing these instruments, it said.

Ind-Ra’s rating of AT1 instruments for weaker government banks could be multiple notches below the long-term issuer rating, factoring in the inherent weakness of the institutions along with the discretionary nature of the security, which could impact its ability to service the instrument, the agency said.

The government has ceded majority in only one bank – when it sold 51 per cent in IDBI Bank Limited to Life Insurance Corporation of India, it noted.

“Once the banks to be privatised are identified, the agency as per its criteria may place the ratings on a rating watch. Based on clarity on the final contours of transacted, the rating agency would take appropriate rating calls,” it said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

India has operationalised over 75,500 Ayushman Bharat-Health and Wellness Centres so far: Govt

SC to consider Centre’s plea, report on ISRO espionage case on April 15

No shortage of COVID-19 vaccine, medicine: Sudhakar

21 at women’s national boxing camp, including top coaches, test positive for COVID-19

Journalists reporting from most adverse situations, should be vaccinated on priority: Kejriwal

Royal funeral offers chance for William, Harry to reconcile

Muslim women have right to invoke extra-judical divorce, rules Kerala HC as it overturns 1972 judgment





Related Articles More

Simplilearn partners with KPMG in India to offer PG programmes

Infosys net profit rises 17.5 pc to Rs 5,076 crore in March qtr; announces Rs 9,200 cr buyback offer

Covid-19 curbs to shave $1.25 billion a week off India’s economy; 140 bps from Q1 GDP: Report

Renault joins hands with CSC Grameen eStore to strengthen presence in rural areas

Govt to implement mandatory gold hallmarking from Jun 1

MUST WATCH

Lord Mahalingeshwara and Lord Venkatramana Face to Face

| Udayavani 14-April-2021 News Bulletin

Singer Mangli Kannu Hodiyaka Song Performance At Maski By Election Campaign

John DSilva | Salient features of Karnataka Industrial Policy 2020-2025

Boy kills minor Girl for rejecting his Proposal | CRIME FILE

Latest Additions

India has operationalised over 75,500 Ayushman Bharat-Health and Wellness Centres so far: Govt

Kerala CM Pinarayi Vijayan discharged from hospital

Congress candidate for Odisha assembly by-election dies

SC to consider Centre’s plea, report on ISRO espionage case on April 15

No shortage of COVID-19 vaccine, medicine: Sudhakar

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.